nach oben

International Journal of Clinical Pharmacy

Erschienen in:

01.02.2010 | Commentary

Developing a consumer reporting program in Malaysia: a novel initiative to improve pharmacovigilance

verfasst von: Subish Palaian, Mohammed Alshakka, Mohamed Izham

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

The national pharmacovigilance program in Malaysia is limited to very few centers and under-reporting of adverse drug reactions (ADRs) is a major limitation. Studies from developed countries have documented the importance and usefulness of consumer reporting of ADRs. Involving consumers in ADR reporting can be very useful in improving the reporting rates in Malaysia. The present article highlights the proposed plan of initiating a consumer based pharmacovigilance program in University Wellness Center located inside the campus of the Universiti Sains Malaysia, Penang, Malaysia.

Nur mit Berechtigung zugänglich

Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009;4(2):e4439.CrossRefPubMed

Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf. 2007;2(1):79–87.CrossRefPubMed

World Health Organization. Requirements for adverse reaction reporting. Geneva, Switzerland: World Health Organization; 1975.

World Health Organization. The importance of pharmacovigilance. Geneva, Switzerland: World Health Organization; 2002.

Haq ASM. Pharmacovigilance initiatives in Malaysia. Drug Info J. 2008;37:143 (S)–148 (S).

Aziz Z, Siang TC, Badarudin NS. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiol Drug Saf. 2007;16(2):223–8.CrossRefPubMed

Fernandopulle RBM, Weerasuriya K. What can consumer adverse drug reaction reporting add to existing health professional-based systems. Drug Saf. 2003;26:219–25.CrossRefPubMed

Langen J, van Hunsel F, Passier A, Van den Berg L, Van Grootheest K. Adverse drug reactions reporting by patients in the Netherlands. Drug Saf. 2008;31(6):515–24.CrossRefPubMed

Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and internationale experience. Br J Clin Pharmacol. 2006;63(2):148–56.CrossRef

10.

Medawar C, Herxheimer A. A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine. Int J Risk Saf Med. 2003;16:5–19.

11.

Al-Haddad M, Izham MIM. The development of the discipline of social and administrative pharmacy at Universiti Sains Malaysia. South Med Rev. 2008;1:3–5.

12.

Palaian S, Izham M, Mishra P. Monitoring adverse drug reactions using the community pharmacists: a preliminary study from Nepal. Drug Saf. 2008;31(10):885–960.

13.

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.PubMed

14.

Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229–32.PubMed

15.

Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27:538.PubMed

Titel: Developing a consumer reporting program in Malaysia: a novel initiative to improve pharmacovigilance
verfasst von: Subish Palaian
Mohammed Alshakka
Mohamed Izham
Publikationsdatum: 01.02.2010
Verlag: Springer Netherlands
Erschienen in: International Journal of Clinical Pharmacy / Ausgabe 1/2010
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI: https://doi.org/10.1007/s11096-009-9342-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

26.04.2024 | Hüft-TEP | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Developing a consumer reporting program in Malaysia: a novel initiative to improve pharmacovigilance

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2010

Medications collected for disposal by outreach pharmacists in Australia

Clinical pharmacy services and solid organ transplantation: a literature review

Analysis and detection of dental prescribing errors at Primary Health Care Units in Brazil

Information sources used by women in Finland who use hormonal contraceptives

CYP2D6*4, CYP3A5*3 and ABCB1 3435T polymorphisms and drug-related falls in elderly people

Statin prescribing in Northern Ireland and England pre and post introduction of the quality and outcomes framework

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Update Innere Medizin

CYP2D64, CYP3A53 and ABCB1 3435T polymorphisms and drug-related falls in elderly people